CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, a company dedicated to transforming healthcare by making biomedical data computable, today announced a multi-year licensing agreement with the Bill & ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 5 min An asthma drug biotech that was ...
CAMBRIDGE, Mass., May 4, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, today announced that it has been named as a finalist in the Fast Company World Changing Ideas Awards in ...
CAMBRIDGE, Mass., March 23, 2021 /PRNewswire/ -- nference, the AI-driven health technology company, today announced publication in EClinicalMedicine of study "Pre-existing conditions are associated ...
Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, ...
CAMBRIDGE, Mass., April 17, 2025 /PRNewswire/ -- nference, a company dedicated to transforming healthcare by making biomedical data computable, today announced a collaboration with BeiGene, Ltd, a ...
nference Media Contact: Matt Hurchik info@nference.net The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party ...
Federated network of 30 million patients powers first-series of 15 foundational studies from Metabolism Agentic Intelligence Atlas (MAIA) toward novel diagnostics, therapeutics, and surgical ...
EHR data company nference on Wednesday launched its real-world evidence generation platform and expanded its existing partnership with the Mayo Clinic. The platform, dubbed nSights, collects ...
This morning nference, maker of a software platform that helps to synthesize biomedical information, scored $60 million in Series C funding. Matrix Capital Management led the round with participation ...
-- One third of patients taking immediate-release, twice-nightly sodium oxybate discontinued treatment, most often due to lack of efficacy; inability to wake up was most common reason for missing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results